Cargando…
Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence
BACKGROUND: ADHD guidelines in the UK suggest that children and adults who respond to pharmacological treatment should continue for as long as remains clinically effective, subject to regular review. To what extent patients persist with treatment from childhood and adolescence into adulthood is not...
Autores principales: | McCarthy, Suzanne, Wilton, Lynda, Murray, Macey L, Hodgkins, Paul, Asherson, Philip, Wong, Ian CK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570395/ https://www.ncbi.nlm.nih.gov/pubmed/23216881 http://dx.doi.org/10.1186/1471-244X-12-219 |
Ejemplares similares
-
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care
por: McCarthy, Suzanne, et al.
Publicado: (2012) -
Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners
por: McCarthy, Suzanne, et al.
Publicado: (2013) -
Functional Impairments Associated With ADHD in Adulthood and the Impact of
Pharmacological Treatment
por: Kosheleff, Alisa R., et al.
Publicado: (2023) -
Pharmacological interventions for ADHD: how do adolescent and adult patient beliefs and attitudes impact treatment adherence?
por: McCarthy, Suzanne
Publicado: (2014) -
Pharmacological approaches of ADHD
por: Cooper, R., et al.
Publicado: (2021)